Life Sciences

  Now that November is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in October – they’re ranked in order of popularity, with number one being the most viewed piece. 

  Thanks to one of my LinkedIn contacts, I was introduced to a newly released “scorecard” that ranks pharmaceutical and biotechnology companies based on their precision medicine efforts. In essence, the organizations who made the cut are the ones moving precision medicine forward. They’re the ones focused on leveraging biomarkers to develop new therapies. 

  On October 15, 2015, my colleague, Kathryn Hanson, presented a webinar on the topic of clinical data warehousing. She provided a high-level overview of the challenges that life sciences companies face when it comes to technology, in particular with the acquisition and management of data (e.g., patient/subject, trial management, safety) from different systems and […]

  Academic research organizations (AROs) and academic medical centers (AMCs) are university-based institutions that conduct scientific research and play a vital role in the development of new drugs and medical devices. Historically, the majority of the research performed by AROs and AMCs has been funded by government divisions like the National Institutes of Health (NIH). […]

  This struck me as interesting: The Boston Globe wrote an article on how doctors at Brigham and Women’s Hospital (BWH) are encouraged to share medical errors. In fact, they are asked to do so, knowing that the information will be published in a case study-like format for the public to see. The objective is […]

  As a user of 23andMe since 2008, I’ve been closely following the company, especially since the FDA told them in 2013 to stop marketing their personal genetics testing service. At last, the FDA has given 23andMe the green light. Not surprisingly, the positive news pushed the cost of the genetics test from $99 to […]

  In our last CAPA-related blog post, we talked about the ability to attach supportive information to CAPA records (case data) in Argus Safety, Oracle’s drug safety and pharmacovigilance system. Today we’ll discuss another way the system can help comply with CAPA rules. CAPA Rule: System must allow the recording of issues and track their […]

  Read this TechCrunch article. Make sure your company’s executives read it, too. According to Google, for the first time ever, more people are performing Google searches on their mobile phones than on their computers. If that doesn’t tell you the digital landscape has changed, I’m not sure what will make you believe it. 

  I’ve written a number of blog posts on the challenges of clinical trial recruitment, and that’s for good reason. According to Dr. Steven Alberts, Chair of Medical Oncology with the Mayo Clinic, only 5% of cancer patients ever enroll in a trial. On top of that, only a fraction of all trials ever complete […]

  According to Jack Bogle, the founder and retired CEO of The Vanguard Group, many large companies based in the U.S. generate 50% of their revenue from outside the country. The same could be said for international companies: a good portion of their revenue is generated outside their respective regions. 

  Last week, Perficient announced that it purchased Rise Foundation, a pre-configured and enhanced version of Microsoft SharePoint, from Blue Rooster. Rise Foundation provides companies with an intranet solution that has the look and feel users expect in today’s digital world. In addition to the impressive UI, the solution enables companies to be more productive […]

  A couple of weeks ago, I shared some statistics that I learned from an FDA blog post about rare diseases. While those numbers will make you cringe, Pfizer will give you hope. They, along with Spark Therapeutics, are teaming up to develop treatments for rare diseases, like hemophilia, through gene therapy. Gene therapy is […]